Noramco Announces Submission of Drug Master File for Lisdexamfetamine Dimesylate ─ Active Pharmaceutical Ingredient

Sadye Matula

Dec 3 2021 Noramco, LLC, a primary North American producer of managed compound bulk Energetic Pharmaceutical Ingredients (APIs) for the pharmaceutical field, today announced it has submitted a Sort II Drug Grasp File (DMF) to the U.S. Foodstuff and Drug Administration (Food and drug administration) for the energetic pharmaceutical component […]